Literature DB >> 33506336

Variability in hair gadolinium concentrations among decedents who received gadolinium-based contrast agents.

Brianne R Duncan1,2, Makoto Hasegawa3,4, Desiree A Marshall5, Luis F Gonzalez-Cuyar5, Michael Paulsen6, Masahiro Kobayashi3, Kenneth R Maravilla7,8, Christopher D Simpson6.   

Abstract

This study utilized laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) to quantify gadolinium in the hair of autopsy cases that had received gadolinium-based contrast agents (GBCAs) before death. Consecutive autopsy cases were reviewed for GBCA injections and subjects who received a single type of GBCA in the year before death were included. Hair samples were analyzed using LA-ICP-MS as a line scan technique and parameters were optimized to maximize instrument sensitivity, accuracy, and precision. Linear regression analyses between hair measures and gadolinium dose were executed. LA-ICP-MS analysis produced a time-resolved record of GCBA exposure, with the position of the gadolinium peak maxima along the hair shaft providing a good estimate for the day that GBCA injection occurred (R2 = 0.46; p = 0.0022); however, substantial within and between subject variation in the position of the GBCA peak was observed. Average area under the curve for gadolinium peaks in the hair samples was a better predictor of gadolinium dose (R2 = 0.41; p = 0.0046), compared to the average of peak maxima concentration. Correlation between area under the curve and dose suggests that LA-ICP-MS analysis of hair may be an effective method to evaluate gadolinium levels in subjects in vivo after exposure to GBCAs. This study demonstrates that analysis of human hair using techniques with high spatial resolution such as LA-ICP-MS has excellent potential to reveal time-dependent signatures of past exposures.

Entities:  

Keywords:  Biomonitoring; GBCA; Gadolinium; Hair; LA-ICP-MS; Postmortem

Mesh:

Substances:

Year:  2021        PMID: 33506336     DOI: 10.1007/s00216-020-03116-3

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  28 in total

1.  Intracranial lesions with high signal intensity on T1-weighted MR images: differential diagnosis.

Authors:  Daniel T Ginat; Steven P Meyers
Journal:  Radiographics       Date:  2012 Mar-Apr       Impact factor: 5.333

Review 2.  Gadolinium Retention and Toxicity-An Update.

Authors:  Miguel Ramalho; Joana Ramalho; Lauren M Burke; Richard C Semelka
Journal:  Adv Chronic Kidney Dis       Date:  2017-05       Impact factor: 3.620

3.  Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging.

Authors:  Robert J McDonald; Jennifer S McDonald; David F Kallmes; Mark E Jentoft; David L Murray; Kent R Thielen; Eric E Williamson; Laurence J Eckel
Journal:  Radiology       Date:  2015-03-05       Impact factor: 11.105

4.  Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy.

Authors:  Tomonori Kanda; Toshio Fukusato; Megumi Matsuda; Keiko Toyoda; Hiroshi Oba; Jun'ichi Kotoku; Takahiro Haruyama; Kazuhiro Kitajima; Shigeru Furui
Journal:  Radiology       Date:  2015-05-05       Impact factor: 11.105

5.  Gadolinium deposition disease: Initial description of a disease that has been around for a while.

Authors:  Richard C Semelka; Joana Ramalho; Ami Vakharia; Mamdoh AlObaidy; Lauren M Burke; Michael Jay; Miguel Ramalho
Journal:  Magn Reson Imaging       Date:  2016-08-13       Impact factor: 2.546

Review 6.  Gadolinium toxicity and treatment.

Authors:  Joana Ramalho; Miguel Ramalho; Michael Jay; Lauren M Burke; Richard C Semelka
Journal:  Magn Reson Imaging       Date:  2016-09-28       Impact factor: 2.546

7.  High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material.

Authors:  Tomonori Kanda; Kazunari Ishii; Hiroki Kawaguchi; Kazuhiro Kitajima; Daisuke Takenaka
Journal:  Radiology       Date:  2013-12-07       Impact factor: 11.105

Review 8.  Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms.

Authors:  Moshe Rogosnitzky; Stacy Branch
Journal:  Biometals       Date:  2016-04-06       Impact factor: 2.949

Review 9.  Gadolinium Deposition in the Brain: Current Updates.

Authors:  Jin Woo Choi; Won-Jin Moon
Journal:  Korean J Radiol       Date:  2018-12-27       Impact factor: 3.500

Review 10.  Gadolinium Retention: A Research Roadmap from the 2018 NIH/ACR/RSNA Workshop on Gadolinium Chelates.

Authors:  Robert J McDonald; Deborah Levine; Jeffrey Weinreb; Emanuel Kanal; Matthew S Davenport; James H Ellis; Paula M Jacobs; Robert E Lenkinski; Kenneth R Maravilla; Martin R Prince; Howard A Rowley; Michael F Tweedle; Herbert Y Kressel
Journal:  Radiology       Date:  2018-09-11       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.